Results 91 to 100 of about 455,569 (249)
Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma
Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel +7 more
wiley +1 more source
Longitudinal progression of retinal nonperfusion in clinically stable diabetic retinopathy
Abstract Purpose To longitudinally assess and quantify changes in retinal nonperfusion (NP) in clinically stable diabetic retinopathy (DR) using ultra‐widefield fluorescein angiography (UWF‐FA) and optical coherence tomography angiography (OCTA). Methods Fifty‐one eyes from thirty‐three patients were followed for a mean of 15.9 ± 11.4 months.
Stela Vujosevic +8 more
wiley +1 more source
Different Mechanisms Causing Macular Hole Development in Proliferative Diabetic Retinopathy
Macular hole can be defined as the retinal defect involving the foveal region. Anatomically, it may be lamellar or full thickness. Other than senile idiopathic cases, trauma, high myopia and retinal detachment may be among the etiological factors ...
Sinan Tatlıpınar
core +1 more source
Automatic non-proliferative diabetic retinopathy screening system based on color fundus image
Background Non-proliferative diabetic retinopathy is the early stage of diabetic retinopathy. Automatic detection of non-proliferative diabetic retinopathy is significant for clinical diagnosis, early screening and course progression of patients. Methods
Zhitao Xiao +7 more
doaj +1 more source
Abstract Purpose Diabetic retinopathy (DR) screening is essential to prevent vision loss, yet rising diabetes prevalence threatens to outpace ophthalmology capacity. Artificial intelligence (AI) systems can triage retinal images to reduce clinician workload, but economic evidence from high‐income, tax‐funded health systems remains limited.
Lars Grønlykke +7 more
wiley +1 more source
Comparison of Intravitreal Bevacizumab versus Triamcinolone for the Treatment of Diffuse Diabetic Macular Edema [PDF]
Background: Our purpose was to compare the effect of triamcinolone and bevacizumab (Avastin) on the retinal thickness and functional outcome in patients with diabetic macular edema. Methods and Materials: A collective of 32 patients, who had been treated
Haritoglou, Christos +6 more
core +1 more source
CD93—An emerging vascular target in cancer therapy
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira +3 more
wiley +1 more source
A Markov model of Diabetic Retinopathy Progression for the Economic Evaluation of a novel DR prognostic device, CHERE Working Paper 2007/14 [PDF]
The initial diagnosis of Diabetic Retinopathy (DR) is often in the advance stages of the condition, as patients are only promoted for an examination when sight has been affected.
Marion Haas, Julia Ting, Donald Martin
core
Resveratrol‐loaded tetrahedral framework nucleic acids (tFNAs‐RSV) enable concurrent anti‐angiogenic and anti‐inflammatory therapy, enhancing ocular delivery and bioactivity. In hypoxia‐induced retinal neovascularisation, tFNAs‐RSV reduce neovascular lesions, vascular leakage and inflammatory infiltration by suppressing HIF‐1, p38 MAPK and NF‐κB p65 ...
Yili Jin +7 more
wiley +1 more source
Objectives. We investigated the relationship between the stage of diabetic retinopathy and pulse wave velocity (PWV). Methods. This was a cross-sectional study of 689 patients (406 men and 283 women) with type 2 diabetes who were admitted to our hospital
Kumiko Tanaka +9 more
doaj +1 more source

